Skip Navigation
Megan McArdle

Megan McArdle - Megan McArdle is the business and economics editor for The Atlantic. She has worked at three start-ups, a consulting firm, an investment bank, a disaster recovery firm at Ground Zero, and the Economist.

Megan McArdle was born and raised on the Upper West Side of Manhattan, and yes, she does enjoy her lattes, as well as the occasional extra dry skim milk cappuccino. Her checkered work history includes three start-ups, four years as a technology project manager for a boutique consulting firm, a summer as an associate at an investment bank, and a year spent as sort of an executive copy girl for one of the disaster recovery firms at Ground Zero . . . all before the age of 30.

While working at Ground Zero, she started Live from the WTC, a blog focused on economics, business, and cooking. She may or may not have been the first major economics blogger, depending on whether we are allowed to throw outlying variables such as Brad Delong out of the set. From there it was but a few steps down the slippery slope to freelance journalism. For the past four years she has worked in various capacities for The Economist, where she wrote about economics and oversaw the founding of Free Exchange, the magazine's economics blog. She has also maintained her own blog, Asymmetrical Information, which moved to the Atlantic Monthly, along with its owner, in August 2007.

Megan holds a bachelor's degree in English literature from the University of Pennsylvania, and an MBA from the University of Chicago. After a lifetime as a New Yorker, she now resides in northwest Washington DC, where she is still trying to figure out what one does with an apartment larger than 400 square feet.

Killing Off the Insurers the Conservative Way

Jan 20 2010, 1:07 PM ET | Comment

So if the Democratic plans are dead, what's left?  What's the Republican plan?

I think those of us who opposed the Democratic bill should have one.  And I happen (ahem) to have a modest little plan right here . . .

Raise the Medicare tax by half a percentage point, and eliminate the tax-deductibiity of health insurance benefits for people making more than $150K a year in household income, $100K for singles.  Then make the federal government the insurer of last resort.  Any medical expenses more than 15% or 20% of household income, get picked up by Uncle Sam.

Yes, people don't like taxes.  But it's a pretty small tax.  The benefit exclusion gets the camel's nose under the tent for ending the employer-health insurance relationship, but it's targeted at groups that a) aren't particularly sympathetic and b) can afford it.  And it answers the central fear people have, which is that they'll end up sick and bankrupt.  20% of your income is a lot.  But it's a manageable amount, especially if, as I suspect, many more people choose to self-insure for the first 15%, and take the differences as wages.

It doesn't answer every single thing we could possibly want--David Cutler argues that compliance with treatment regimes is already so low that we don't want to erect any cost barriers.  But it's progressive, solves the biggest part of the problem, and it still leaves the market for most health care services intact.

In fact, I think it will be a more powerful impetus for cost control than any excise tax or IMAC could have been, because consumers will be making the decisions by themselves, not sullenly fighting an insurer, employer, or government bureaucrat.  It doesn't exert cost pressures on end of life care, which will certainly blow the caps--but I found it pretty implausible that we were ever going to find the political will to cut off marginal treatments to the sickest and most vulnerable.  And in other areas, it could make a big difference.

Meanwhile, whatever awesome plans Democrats had to control costs in Medicare and Medicaid, they should implement and show us all how well they work.

That's my suggestion.  I'm sure you can pick holes in it, and it might be pretty ugly by the time the lobbyists got through with it.  On the other hand, it just might work.


Presented by

Join the Discussion

After you comment, click Post. If you’re not already logged in you will be asked to log in or register.

Comments powered by Disqus

Correspondents

View All

Subscribe Now

10 ISSUES. SAVE 59% JUST $2.45 PER COPY

Newsletters

Sign up to receive our two free newsletters

This Week on TheAtlantic.com (sample)

This Month in The Atlantic (sample)

5 Best Columns from The Atlantic Wire (sample)

I want to receive updates from our partners and sponsors

Megan McArdle from the Magazine

The Great Stock Myth

Why the market’s rate of return—and your nest egg—may never recover

Deficits Matter

No Refills

In 2009, only 25 new drugs were approved—less than half the number in the mid-’90s. Why…